Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has induced a sense of panic around the world as the disease is highly contagious and has been spreading in full swing. This study was aimed to investigate SARS-CoV-2 associated epidemiology and clinical outcomes in Bangladesh in order to understand the future course of COVID-19 pandemic and develop prevention approaches. A cross-sectional retrospective interview based study was conducted on RT-PCR confirmed COVID-19 patients admitted in Chattagram Maa O Shishu General Hospital Chittagong, Bangladesh and who recovered four weeks prior to the interview date. Of the total 500 patients, 7% patient are asymptomatic where as for the symptoms associated with COVID-19 fever (85%) and cough (70%) were the most prominent among cases. Our study has revealed that among the age groups, the 40-70 showed the highest infection rate (74.7%) and in terms of gender, the prevalence of Covid-19 infection in males (65%) was 2 times more than that in females (35%). Diabetes was found about (40%) and Hypertension was found (42%), so diabetic and hypertesive patient are more affected. The most used drug is Enoxaparin sodium, Methylprednisolone Na Succinate, Montelucast, fexofenadinb, Doxycyclline, Doxofylline, zinc, vitamin-C, D and about 60% patient need oxygen supply. The most complication after recovery is weak -fatigue, cough & breathing problem.
Highlights
COVID-19 is a very new disease and there is still finding out concerning it
This virus is distinguished as severe the acute respiratory syndrome corona virus 2 (SARS-CoV-2), and the disease name is corona virus disease 2019 (COVID-19)
This virus has a high degree of the lethality than other the endemic viruses and it is more lethal to the humans compared to earlier emerging epidemics of SARS-CoV-1 in 2003 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012
Summary
COVID-19 is a very new disease and there is still finding out concerning it. It is currently considered that virus too much spreads by joining itself to the droplets in air enter body through our mucus membranes like in eyes, nose and mouth [1]. Very beginning on the 31 December 2019, Chinese authorities accounted to World Health Organization a rising novel corona virus in the patients from Wuhan, Hubei province [2] This virus is distinguished as severe the acute respiratory syndrome corona virus 2 (SARS-CoV-2), and the disease name is corona virus disease 2019 (COVID-19). This virus has a high degree of the lethality than other the endemic viruses and it is more lethal to the humans compared to earlier emerging epidemics of SARS-CoV-1 in 2003 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 Both SARS-CoV-1 and MERS-CoV have common ancestry with viruses found in bats. The test may be negative in the early days of presentation [9]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
